AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

MIRA Pharmaceuticals Inc. (MIRA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

1.11

-0.05 (-4.31%)

At close: Feb 20, 2025, 3:59 PM

1.12

0.45%

After-hours: Feb 20, 2025, 05:12 PM EST

undefined% (undefined)

Bid	1.11
Market Cap	18.47M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.55
PE Ratio (ttm)	-2.03
Forward PE	n/a
Analyst	Buy

Ask	1.15
Volume	151,441
Avg. Volume (20D)	388,179
Open	1.16
Previous Close	1.16
Day's Range	1.11 - 1.16
52-Week Range	0.51 - 5.01
Beta	undefined

About MIRA

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by...

[Show more]

Industry Drug Manufacturers - General

Sector Healthcare

IPO Date Aug 14, 2023

Employees 2

Stock Exchange NASDAQ

Ticker Symbol MIRA

Website https://mirapharmaceuticals.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for MIRA stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 1155.61% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Why Price Moved

3 months ago

+21.71%

MIRA Pharmaceutical shares are trading higher afte... Unlock content with Pro Subscription

4 months ago

+8.41%

MIRA Pharmaceuticals shares are trading higher after the company announced new preclinical data for Ketamir-2,

News

7 months ago · investorplace.com

Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?

Mira Pharmaceuticals (NASDAQ: MIRA ) stock is down on Tuesday as the clinical-stage pharmaceutical company's shares come off of a major rally on Monday. Shares of MIRA stock closed out Monday's normal...

8 months ago · benzinga.com

MIRA Announces Positive Test Results

The company announced that it achieved positive preclinical study results for Ketamir-2, its Novel Oral ketamine Analog.

11 months ago · investorplace.com

Why Is Mira Pharmaceuticals (MIRA) Stock Up 52% Today?

Mira Pharmaceuticals (NASDAQ: MIRA ) stock is rising on Friday after it provided investors with an interesting preclinical trial update. The company has been investigating its preclinical studies of M...

1 year ago · pennystocks.com

3 Hot Penny Stocks To Watch Before The September Fed Meeting

Penny stocks represent an exciting yet risky path to profits for active investors. Defined as stocks priced under $5 per share, these cheap equities boast the potential for astronomical returns on min...

1 year ago · marketwatch.com

Cannabis pharma Mira Pharmaceuticals ups IPO size

Cannabis-focused Mira Pharmaceuticals Inc. increased the size of its initial public offering to 1.2 million shares and set the offering price at $7 a share, according to a filing late Friday. Mira ear...

1 year ago · seekingalpha.com

IPO Update: Mira Pharmaceuticals Aims For Mini-IPO

Mira Pharmaceuticals, Inc. has filed proposed terms for a $7 million U.S. IPO, offering 1 million shares at a midpoint price of $7.00 each. The firm is developing a drug treatment candidate for anxiet...